French researchers have used a rodent study to show how their experimental treatment for autism – the potent diuretic bumetanide – may flip a biochemical switch in the brain. Their report appears today in Science.
A review of more than 29,000 studies identified 27 autism therapies as worthy to be called "evidence-based." This is up from 24 autism therapies that the authors identified as solidly backed by research in their first review, published in 2008.
In this month’s “Autism Matters” podcast, autism researcher Judith Gould and autism self-advocate and author Robyn Steward discuss issues surrounding women with autism, from current research to safety issues, as well as potential differences between men and women on the spectrum.
Autism Speaks most heartily congratulates autism researcher Elaine Hsiao for making Forbes' 2013 list of 30 Under 30 in Science and Healthcare.